Ambey Laboratories Ltd
AMBEYAmbey Laboratories Ltd
AMBEYMaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹211 cr, stock is ranked 2,313
High RiskStock is 5.57x as volatile as Nifty
78.657.09% (-6.00)
78.657.09% (-6.00)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 8.93 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
31.53 | 3.76 | 1.24% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Ambey Laboratories Limited is an India-based manufacturing company founded in 1985. The company is engaged in the manufacturing and trading of chemical products, pharmaceuticals, medicinal chemical, and botanical products.
Peers
Compare with peersGujarat Fluorochemicals Ltd
PE Ratio
79.75
1Y Return
14.47%
Buy Reco %
70.00
Aarti Industries Ltd
PE Ratio
60.14
1Y Return
48.84%
Buy Reco %
41.18
Vinati Organics Ltd
PE Ratio
66.12
1Y Return
13.78%
Buy Reco %
45.45
Navin Fluorine International Ltd
PE Ratio
64.42
1Y Return
18.41%
Buy Reco %
60.00
Supreme Petrochem Ltd
PE Ratio
47.37
1Y Return
96.18%
Buy Reco %
50.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Earnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
Financial Year | FY 2021 | FY 2022 | FY 2023 | TTM | ||||
---|---|---|---|---|---|---|---|---|
Total Revenue | 82.42 | 85.11 | 107.43 | — | ||||
Raw Materials | 0.00 | 0.00 | 0.00 | — | ||||
Power & Fuel Cost | 1.60 | 1.62 | 2.07 | |||||
Employee Cost | 1.68 | 1.70 | 2.22 | |||||
Selling & Administrative Expenses | 2.88 | 3.38 | 3.86 | |||||
Operating & Other expenses | 65.84 | 67.55 | 88.23 | |||||
EBITDA | 10.42 | 10.86 | 11.05 | — | ||||
Depreciation/Amortization | 3.22 | 2.97 | 2.96 | — | ||||
PBIT | 7.20 | 7.89 | 8.09 | — | ||||
Interest & Other Items | 4.11 | 3.06 | 1.87 | — | ||||
PBT | 3.09 | 4.83 | 6.22 | — | ||||
Taxes & Other Items | -7.25 | 1.26 | 1.65 | — | ||||
Net Income | 10.34 | 3.57 | 4.57 | — | ||||
EPS | 211.30 | 31.53 | 25.75 | — | ||||
DPS | 0.00 | 0.00 | 0.00 | — | ||||
Payout ratio | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
MaterialsSpecialty ChemicalsCompare valuation on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Ambey Laboratories Ltd | 46.21 | 8.93 | — |
Gujarat Fluorochemicals Ltd | 79.75 | 6.28 | 0.10% |
Aarti Industries Ltd | 60.14 | 4.73 | 0.14% |
Vinati Organics Ltd | 66.12 | 9.63 | 0.34% |
Price Comparison
Compare AMBEY with any stock or ETFCompare AMBEY with any stock or ETF
AMBEY
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Feb 2024
Jul 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AMBEY has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 25.08%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant